EE507 Pre-Progression Health State Utility Values From the TALAPRO-2 Clinical Trial in Patients With Metastatic Castration-Resistant Prostate Cancer Unselected for DDR Mutations

Saved in:
Bibliographic Details
Published inValue in health Vol. 26; no. 12; p. S149
Main Authors Niyazov, A., Simou, E., Kirker, M., Houghton, K., Le Moine, J.G., Chang, J., Yarr, S., Barnett, C., Mladsi, D.D.
Format Journal Article
LanguageEnglish
Published 01.12.2023
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
DOI:10.1016/j.jval.2023.09.772